UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.366

Sortiert nach

Complication rates of CT-guided transthoracic lung biopsy: meta-analysis

European radiology, 2017-01, Vol.27 (1), p.138-148

2017

Link zum Volltext

Verfügbarkeit prüfen

Using genomic scars to select immunotherapy beneficiaries in advanced non-small cell lung cancer

Scientific reports, 2023-04, Vol.13 (1), p.6581-6581, Article 6581

2023

Link zum Volltext

Verfügbarkeit prüfen

Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression

PloS one, 2017-08, Vol.12 (8), p.e0182885-e0182885

2017

Link zum Volltext

Verfügbarkeit prüfen

Maintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial

Annals of oncology, 2014-05, Vol.25 (5), p.1044-1052

2014

Link zum Volltext

Verfügbarkeit prüfen

Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor

Annals of oncology, 2012-11, Vol.23 (11), p.2937-2942

2012

Link zum Volltext

Verfügbarkeit prüfen

Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literature

Critical reviews in oncology/hematology, 2016-04, Vol.100, p.107-116

2016

Link zum Volltext

Verfügbarkeit prüfen

Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin–gemcitabine or carboplatin–paclitaxel: NVALT-3 a phase III study

Annals of oncology, 2011-07, Vol.22 (7), p.1520-1527

2011

Link zum Volltext

Verfügbarkeit prüfen

Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): A meta-analysis of individual data from 1764 patients

Annals of oncology, 2006-03, Vol.17 (3), p.473-483

2006

Link zum Volltext

Verfügbarkeit prüfen

Costs of non-small cell lung cancer in the Netherlands

Lung cancer (Amsterdam, Netherlands), 2016-01, Vol.91, p.79-88

2016

Link zum Volltext

Verfügbarkeit prüfen

A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC)

Annals of oncology, 2013-09, Vol.24 (9), p.2382-2389

2013

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study

Annals of oncology, 2013-11, Vol.24 (11), p.2860-2865

2013

Link zum Volltext

Verfügbarkeit prüfen

Respiratory level tracking with visual biofeedback for consistent breath-hold level with potential application in image-guided interventions

European radiology experimental, 2018-09, Vol.2 (1), p.22-22, Article 22

2018

Link zum Volltext

Verfügbarkeit prüfen

Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: From lab to clinic

Critical reviews in oncology/hematology, 2007-01, Vol.61 (1), p.52-69

2007

Link zum Volltext

Verfügbarkeit prüfen

First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging

Annals of oncology, 2011-03, Vol.22 (3), p.559-566

2011

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2013-11, Vol.82 (2), p.276-281

2013

Link zum Volltext

Verfügbarkeit prüfen

Molecular Tumor Boards: current practice and future needs

Annals of oncology, 2017-12, Vol.28 (12), p.3070-3075

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment and survival of patients with small-cell lung cancer: small steps forward, but not for patients >80

Annals of oncology, 2012-04, Vol.23 (4), p.954-960

2012

Link zum Volltext

Verfügbarkeit prüfen

EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer

European journal of cancer (1990), 2019-08, Vol.117, p.60-68

2019

Link zum Volltext

Verfügbarkeit prüfen

Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: A first step toward implementing a multidisciplinary, evidence-based guideline

Lung cancer (Amsterdam, Netherlands), 2006-10, Vol.54 (1), p.117-124

2006

Link zum Volltext

Verfügbarkeit prüfen

Circulating tumor cells are prognostic in SCLC, but still lack clinical application

Annals of oncology, 2019-07, Vol.30 (7), p.1031-1033

2019

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy in elderly small-cell lung cancer patients: yes we can, but should we do it?

Annals of oncology, 2011-04, Vol.22 (4), p.821-826

2011

Link zum Volltext

Verfügbarkeit prüfen

Large cell neuroendocrine carcinoma with a solitary brain metastasis and low Ki-67: a unique subtype

Endocrine Connections, 2019-12, Vol.8 (12), p.1600-1606

2019

Link zum Volltext

Verfügbarkeit prüfen

Variation in causes of death in patients with non-small cell lung cancer according to stage and time since diagnosis

Annals of oncology, 2015-05, Vol.26 (5), p.902-907

2015

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC)

Lung cancer (Amsterdam, Netherlands), 2019-04, Vol.130, p.179-186

2019

Link zum Volltext

Verfügbarkeit prüfen

DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile

Lung cancer (Amsterdam, Netherlands), 2019-12, Vol.138, p.102-108

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.366

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.269)
Mit Volltextzugriff
(1.213)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(996)
Life Sciences & Biomedicine
(887)
Humans
(708)
Male
(443)
Female
(423)
Biological And Medical Sciences
(349)
Middle Aged
(309)
Medical Sciences
(296)
Adult
(277)
Aged
(269)
Oncology
(203)
Animals
(175)
Surgery
(110)
Technology
(90)
Treatment Outcome
(84)
Neurosciences & Neurology
(83)
Patients
(80)
Fundamental And Applied Biological Sciences. Psychology
(75)
Lung Cancer
(73)
Pharmacology. Drug Treatments
(72)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

Complication rates of CT-guided transthoracic lung biopsy: meta-analysis

Using genomic scars to select immunotherapy beneficiaries in advanced non-small cell lung cancer

Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression

Maintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial

Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor

Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literature

Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin–gemcitabine or carboplatin–paclitaxel: NVALT-3 a phase III study

Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): A meta-analysis of individual data from 1764 patients

Costs of non-small cell lung cancer in the Netherlands

A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC)

A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study

Respiratory level tracking with visual biofeedback for consistent breath-hold level with potential application in image-guided interventions

Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: From lab to clinic

First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging

A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer

Molecular Tumor Boards: current practice and future needs

Treatment and survival of patients with small-cell lung cancer: small steps forward, but not for patients >80

EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer

Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: A first step toward implementing a multidisciplinary, evidence-based guideline

Circulating tumor cells are prognostic in SCLC, but still lack clinical application

Chemotherapy in elderly small-cell lung cancer patients: yes we can, but should we do it?

Large cell neuroendocrine carcinoma with a solitary brain metastasis and low Ki-67: a unique subtype

Variation in causes of death in patients with non-small cell lung cancer according to stage and time since diagnosis

Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC)

DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile

Suchergebnisse filtern